IRHIS

 

Interoperable Remote Health Innovation Brought to Scale (IRHIS)

Funding Source: European Union
Programme: I3-2023-INV2a
Reference: 101160941

Project duration: 2nd of September 2024- 1st of September 2027

IRHIS aims to accelerate the upscale of remote health innovations and innovators offering AI-powered, cutting-edge sensor solutions, wearable devices, and remote monitoring solutions across three critical EU remote care areas: musculoskeletal rehabilitation, neurological disorder treatment, and critical patient conditions. By leveraging Big Data, Artificial Intelligence (AI), and Machine Learning, IRHIS will personalise clinical paths and improve patient outcomes while ensuring regulatory compliance and cross-device interoperability.

21 partners from 13 European regions intend to demonstrate a portfolio of 3 interregional investments of 8 technologies developed by EU MedTech SMEs, to jointly boost and deploy innovative remote care solutions, embedding Scale-Ups from transition and less developed regions into global value chains.  To that aim, the 3 DemoScale labs will facilitate the demonstration of 8 key TRL6+ technologies and accelerate their faster market uptake. The project IRHIS will federate less developed, transition and developed regions around joint innovation investments and will support the advancement of regional smart specialisation around the shared S3 priority Medical Technology towards commercialisation and scale-up.

The consortium of 21 partners:

Coordinator: Health technology cluster iVita 

P1: Sveikatos technologijų klasteris iVita, VšĮ  (Lithuania)

P2: IDRO BV (Belgium)

P3: APOKATASTASI AE (Greece)

P4: Ergobyte Pliroforiki Anonymi Etaireia Anaptyxis Logismikou kai Diadiktyakon Efarmogon (Greece)

P5: FUNDACION UNIVERSITARIA SAN ANTONIO (Spain)

P6: Zive UAB (Lithuania)

P7: CHECK POINT CARE LTD. (Bulgaria)

P8: ELLINIKOS SYNERGATIKOS SCHIMATISMOS PSIFIAKIS YGEIAS IDIOTIKI KEFALAIOYXIKI ETAIREIA (Greece)

P9: GNOMON PLIROPHORIKIS AE (Greece)

P10: EUC INOVAÇAO PORTUGAL, UNIPESSOAL, LDA (Portugal)

P11: DIGITAL HEALTH AND INNOVATION CLUSTER BULGARIA (Bulgaria)

P12: VILIMED UAB (Lithuania)

P13: TECHNISCHE UNIVERSITEIT EINDHOVEN (Netherlands)

P14: Ronald van Broekhoven (Netherlands)

P15: Isokine bvba (Belgium)

P16: ARISTOTELIO PANEPISTIMIO THESSALONIKIS (Greece)

P17: AICRUM IT SL (Spain)

P18: Inuva hub s.l. (Spain)

P19: CRETE MEDICAL PRIVATE MULTISURGERY MEDICAL SOCIETE ANONYME (Greece)

P20: SERVICIO MURCIANO DE SALUD (Spain)

P21: UAB DE FUTURO (Lithuania)

 

IRHIS aims to demonstrate and scale 8 key technologies developed by EU MedTech SMEs, embedding Scale-Ups from less developed regions into global value chains, thereby boosting innovative remote care solutions.

  1. Scale Remote Health Innovations: Accelerate the upscale of AI-powered sensor solutions, wearable devices, and remote monitoring technologies.
  2. Enhance Musculoskeletal Care: Integrate 3 medical sensor technologies into a remote care platform for personalised rehabilitation.
  3. Improve Neurological Treatments: Develop automated rehab technologies to reduce misdiagnoses and enhance prevention for neurological disorders.
  4. Advance Critical Care Monitoring: Integrate advanced sensors and AI predictive analytics for ICU remote monitoring and early sepsis detection.
  5. Foster Ecosystem Growth: Build a thriving interregional ecosystem for Advanced Remote Care technologies, enhancing market adoption and financial access.

IRHIS will deploy investments related to the use of digital tools to stimulate prevention, enable feedback, and enhance interaction with healthcare providers. This initiative aims to materialize the Internet of Medical Things (IoMT) by creating a network of interconnected medical devices, applications, and health information systems. A key component of this investment strategy involves the establishment of the pan-European DemoScale Lab environment, designed to position IRHIS demonstrators from LDR and initiate the Remote Care Investment Club.

 

#IRHIS #I3 #EISMEA